Atlas Trials

SQ-Kyrin-T First-in-man Feasibility Study

Clinical trial NCT06605313 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06605313
Sponsor
Shanghai Shenqi Medical Technology Co., Ltd
Status
ACTIVE_NOT_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Tricuspid Regurgitation
Start date
2022-06-16
Primary completion
2022-12-07
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.